it will be the first approved treatment for Alagille syndrome. The therapy is currently being evaluated in late-stage clinical studies in other rare cholestatic liver diseases & has received BTD for ALGS and PFIC type 2 and ODD for ALGS
Incisive News in 3 Shots.